Silver Book

Silver Book Fact

An antibiotic stewardship program saved $17 million over 8 years

An antibiotic stewardship program saved a total of $17 million over 8 years, with antibiotic costs rising $1 million in the first year after discontinuation.

Standiford H, Chan S, Tripoli M, Weekes E, et al. Antimicrobial Stewardship at a Large Tertiary Care Academic Medical Center: Cost analysis, before, during, and after a 7-year program. Infect Control Hosp Epidemiol. 2015; 33(4): 338-345. https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology/article/antimicrobial-stewardship-at-a-large-tertiary-care-academic-medical-center-cost-analysis-before-during-and-after-a-7year-program/95CB82200F2691F29FFEA701DBDF928E

Reference

Title
Antimicrobial Stewardship at a Large Tertiary Care Academic Medical Center: Cost analysis, before, during, and after a 7-year program
Publication
Infect Control Hosp Epidemiol
Publisher
University of Chicago Press
Publication Date
2015
Authors
Standiford H, Chan S, Tripoli M, Weekes E, et al
Volume & Issue
Volume 33, Issue 4
Pages
338-345
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Publications

Healthcare-Associated Infections Factsheet

 https://www.silverbook.org/wp-content/uploads/2015/06/Screen-Shot-2015-06-30-at-3.02.28-PM.png Thumbnail

Related Facts

  • Over 8 years infection control practices saved ~27,000 lives and $1.8 billion
    Infection control practices saved an estimated 27,000 lives and $1.8 billion in medical costs between 2001 and 2009.  
  • Only a 20% reduction in drug-resistant infections would save $3.2 – $5.2 billion each year
    A 20% reduction in drug-resistant infections would save between 5.7 and 11.3 million additional hospital days and between $3.2 and $5.2 billion in healthcare costs, each year.  
  • New antibacterial agents between 1983 and 2012
    Total number of new antibacterial agents is in decline  
  • Negative value of antibiotics to drug companies
    The value of an antibiotic to a drug company is negative $50 million- compared to the positive value of $1 billion for a new musculoskeletal drug.  
  • Reduction of central-line infections saved ~ 1,800 lives and $280 million
    Standardization of best practice interventions reduced central line-associated blood stream infections and saved an estimated 1,800 lives and $280 million.